Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Abstract

Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate.

B M Bennett, S M Kobus, J F Brien, K Nakatsu and G S Marks
Journal of Pharmacology and Experimental Therapeutics May 1986, 237 (2) 629-635;
B M Bennett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S M Kobus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J F Brien
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K Nakatsu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G S Marks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 237 no. 2 629-635
PubMed 
3084763

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online May 1, 1986.


Author Information

  1. B M Bennett,
  2. S M Kobus,
  3. J F Brien,
  4. K Nakatsu and
  5. G S Marks

    Statistics from Altmetric.com

    Article usage

    Article usage: March 2000 to September 2023

    AbstractFullPdf
    Mar 2000200
    Mar 2001200
    May 2001100
    Jan 2002100
    Mar 2002100
    Jul 2003400
    Aug 2003300
    Sep 2003400
    Oct 2003700
    Nov 2003400
    Dec 2003100
    Jan 2004800
    Feb 2004300
    Mar 2004300
    Apr 2004400
    May 2004600
    Jun 2004800
    Jul 20041000
    Aug 2004500
    Sep 2004300
    Oct 2004200
    Nov 2004300
    Dec 2004300
    Jan 2005700
    Feb 2005400
    Mar 2005300
    Apr 2005100
    May 2005100
    Jun 2005100
    Sep 2005100
    Oct 2005200
    Nov 2005100
    Dec 2005100
    Jan 2006100
    Feb 2006100
    Mar 2006100
    Apr 2006300
    May 2006101
    Jun 2006100
    Jul 2006201
    Sep 2006102
    Oct 2006400
    Nov 2006303
    Dec 2006103
    Jan 2007002
    Feb 2007100
    Apr 2007700
    May 2007102
    Jun 2007101
    Jul 2007200
    Aug 2007100
    Sep 2007206
    Oct 2007003
    Nov 2007100
    Feb 2008100
    Mar 2008602
    Apr 2008201
    May 2008301
    Jun 20081001
    Jul 2008203
    Aug 2008101
    Sep 2008400
    Oct 2008300
    Nov 2008500
    Jan 2009302
    Feb 2009200
    Mar 2009001
    Apr 2009100
    May 2009100
    Jun 2009200
    Jul 2009501
    Aug 2009100
    Sep 2009500
    Oct 2009800
    Nov 2009302
    Dec 2009600
    Jan 2010101
    Feb 2010300
    Mar 2010100
    Apr 2010701
    May 2010200
    Jun 2010200
    Jul 2010100
    Aug 2010400
    Sep 2010100
    Oct 2010202
    Dec 2010400
    Jan 2011200
    Mar 2011501
    Apr 2011201
    May 2011800
    Jun 2011600
    Jul 2011402
    Aug 2011500
    Sep 2011500
    Oct 2011300
    Nov 2011600
    Dec 2011900
    Jan 2012701
    Feb 2012301
    Mar 20121100
    Apr 2012905
    May 2012900
    Jun 2012500
    Jul 20121000
    Aug 2012300
    Sep 2012500
    Oct 2012500
    Nov 2012601
    Dec 2012203
    Jan 2013500
    Feb 2013501
    Mar 2013500
    Apr 20131000
    May 2013300
    Jun 2013203
    Aug 2013200
    Oct 2013300
    Nov 2013200
    Dec 2013504
    Jan 2014200
    Feb 2014300
    Mar 2014300
    May 2014101
    Jul 2014200
    Aug 2014100
    Sep 2014101
    Oct 2014100
    Dec 2014200
    Mar 2015100
    Apr 2015100
    Jul 2015100
    Aug 2015100
    Sep 2015200
    Oct 2015001
    Dec 2015600
    Jan 2016101
    Feb 2016200
    Mar 2016302
    May 2016201
    Jun 2016400
    Jul 2016100
    Aug 2016100
    Sep 2016200
    Oct 2016401
    Nov 2016400
    Dec 2016400
    Jan 2017200
    Feb 2017201
    Mar 2017800
    Jun 2017700
    Jul 2017300
    Aug 2017300
    Sep 2017300
    Oct 2017701
    Nov 2017700
    Dec 2017701
    Jan 2018400
    Feb 2018800
    Mar 20181301
    Apr 20181002
    May 2018301
    Jun 2018600
    Jul 2018101
    Aug 2018501
    Sep 2018501
    Oct 2018400
    Nov 2018400
    Dec 2018300
    Jan 2019300
    Feb 2019201
    Mar 2019101
    Apr 2019800
    May 2019100
    Jun 2019100
    Jul 2019002
    Aug 2019200
    Sep 2019301
    Oct 2019702
    Nov 2019801
    Dec 2019701
    Jan 2020500
    Feb 2020700
    Mar 2020201
    Apr 2020100
    May 2020100
    Jun 2020300
    Jul 2020400
    Sep 20201000
    Oct 20201000
    Nov 2020600
    Dec 2020800
    Jan 2021501
    Feb 20211002
    Mar 20211200
    Apr 2021400
    May 2021400
    Jun 2021400
    Jul 2021600
    Aug 2021500
    Sep 20211800
    Oct 2021500
    Nov 20211300
    Dec 2021600
    Jan 2022600
    Feb 20221000
    Mar 2022400
    Apr 20221300
    May 2022501
    Jun 2022800
    Jul 2022800
    Aug 2022700
    Sep 2022800
    Oct 2022500
    Nov 20221300
    Dec 2022200
    Jan 2023400
    Feb 2023500
    Mar 2023600
    Apr 2023500
    May 2023600
    Jun 2023600
    Jul 20231100
    Aug 2023400
    Sep 2023300

    PreviousNext
    Back to top

    In this issue

    Journal of Pharmacology and Experimental Therapeutics
    Vol. 237, Issue 2
    1 May 1986
    • Table of Contents
    • Table of Contents (PDF)
    • Index by author
    • Back Matter (PDF)
    • Editorial Board (PDF)
    • Front Matter (PDF)
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate.
    (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
    (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Abstract

    Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate.

    B M Bennett, S M Kobus, J F Brien, K Nakatsu and G S Marks
    Journal of Pharmacology and Experimental Therapeutics May 1, 1986, 237 (2) 629-635;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Abstract

    Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate.

    B M Bennett, S M Kobus, J F Brien, K Nakatsu and G S Marks
    Journal of Pharmacology and Experimental Therapeutics May 1, 1986, 237 (2) 629-635;
    Reddit logo Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About JPET
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0103 (Online)

    Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics